1. Market Research
  2. > Pharmaceutical
  3. > Biopharmaceutical Market Trends
Global Sterile Filtration Industry

Global Sterile Filtration Industry

  • February 2022
  • 381 pages
  • ID: 5960185
  • Format: PDF
  • Global Industry Analysts

Summary

Table of Contents

Abstract:

What`s New for 2022?
-Global competitiveness and key competitor percentage market shares
-Market presence across multiple geographies - Strong/Active/Niche/Trivial
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year

Global Sterile Filtration Market to Reach $7.3 Billion by 2026

Sterilization and filtration is gaining increasing importance across multiple industries owing to the burden of compliance. Hitherto the pharmaceutical/biological and food & beverage industries were the primary users of sterilization systems. Even within the food & beverage industry, the focus on sterilization and prevention of containment have become prime focus areas owing to a string of contamination issues across the world. In such a scenario, provision of contaminant-free food/beverages has emerged as a key trend. Hitherto, heat was the primary mode of sterilization. However, many factors such as loss of product characteristics, and high costs of energy are driving food processors to migrate to sterile filtration. In addition, many products such as biopharmaceuticals are not suitable for heat sterilization, leading to increasing use of membrane filters. Even in the food & beverage industry, sterile filtration is gaining increasing acceptance owing to lower process time and costs. Sterile filtration can be achieved through sieving, adsorption, and clogging. Sieving provides the best sterile filtration as the membrane filters block and trap all particles with sizes above the membrane pores. Depending on the type of sterilization required, process industries utilize filters with appropriate size. The biopharmaceutical industry and aseptic rooms have low tolerance levels for contamination and use multiple filters in series or parallel to achieve sterilization. When used in series, multiple filters of the same or different pore sizes are used as per needs.

Amid the COVID-19 crisis, the global market for Sterile Filtration estimated at US$4.8 Billion in the year 2020, is projected to reach a revised size of US$7.3 Billion by 2026, growing at a CAGR of 7.2% over the analysis period. Cartridge Filters, one of the segments analyzed in the report, is projected to grow at a 6.9% CAGR to reach US$2.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Capsule Filters segment is readjusted to a revised 7.7% CAGR for the next 7-year period. This segment currently accounts for a 26.4% share of the global Sterile Filtration market.

The U.S. Market is Estimated at $1.7 Billion in 2021, While China is Forecast to Reach $1 Billion by 2026

The Sterile Filtration market in the U.S. is estimated at US$1.7 Billion in the year 2021. The country currently accounts for a 33.93% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$1 Billion in the year 2026 trailing a CAGR of 9.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$1.1 Billion by the close of the analysis period.

The market is expected to benefit from increased production of biologics. In the pharmaceutical sector, the biotherapeutics is one of the most rapidly growing segments. Key factors driving the growth of biotherapeutics market include the capability to treat diseases that were earlier untreatable. In addition, biotherapeutics are known for its safety and efficiency. There are several other factors stimulating the biotherapeutics market growth. For instance, technological developments in several associated fields is leading to the development of large collection of plausible drug targets and also considerable progress in the perception of diseases. Furthermore, the synthesis of human insulin and Monoclonal Antibodies (MABs) are also factors helping to propel the biotherapeutics market growth. The existing scenario in the field of biologics is set to drive growth of biotherapeutic medicines in the near term. The number of biotech patents applications continues to increase by around 25% annually.

The biological drugs industry is increasingly focusing on sterile filtration to achieve contaminant-free products. Drugs are highly heat sensitive and filtration plays a key role in ensuring the integrity of these drugs. In addition, there is an increasing focus on bioburden by both regulators and companies as contamination of drugs poses high risks for patients, including fatal risks. From a manufacturer point of view, contamination also includes financial risk as closure of plants could lead to losses in billions of dollars. Moreover, the collateral damage to reputation could and remedial measures from regulators could also severely affect the companies. Even if a batch of drugs does not pass the quality parameters, the lost opportunity in terms of market and financial losses are very high. Sterile filtration therefore plays a significant role in the biopharmaceutical industry as an effective method for sterilizing products. It can be technically very challenging to terminally sterilize biopharmaceutical products, making it vital to use sterilizing-grade filtration for such aseptic processing applications. Heat sterilization, or any other method requiring an input of energy into biotechnology drug products, can cause unwanted degradation to the product, which can only be prevented through the use of sterilized filtration.

Sterilizing membrane filtration as a method for physically removing microbes from heat-sensitive biopharmaceutical fluids has been practiced for several decades, and there is already a high level of expertise and experience in the industry. The process has been well understood and has proved itself to be reliable when validated properly. Sterile filtration is also commonly required for reducing the levels of bioburden within process streams for avoiding the potential formation of a biofilm. Process validation of sterilizing-grade filters is an essential task for ensuring and verifying the filter`s performance within the fluid stream and process conditions.

Membrane Filters Segment to Reach $1.2 Billion by 2026

In the global Membrane Filters segment, USA, Canada, Japan, China and Europe will drive the 8.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$594.7 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$145.3 Million by the year 2026, while Latin America will expand at a 9.6% CAGR through the analysis period.

Select Competitors (Total 40 Featured) -
  • 3M
  • Alfa Laval AB
  • Merck KGaA
  • Pall Corporation
  • Parker Hannifin Corporation
  • Porvair Filtration Group
  • Sartorius AG
  • Starlab Scientific Co., Ltd
  • Sterlitech Corporation
  • Thermo Fisher Scientific

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Biopharmaceuticals Contract Manufacturing Market Research Report by Product, Source, Contract Type, Service, Scale of Operation, Therapeutic Applications, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 3949
  • June 2022
  • 206 pages

Biopharmaceuticals Contract Manufacturing Market Research Report by Product (Biologics and Biosimilar), Source, Contract Type, Service, Scale of Operation, Therapeutic Applications, Region (Americas, Asia-Pacific, ...

  • World
  • Biopharmaceutical
  • Industry analysis

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on